CYBB and tuberculosis: To investigate whether immature neutrophil-specific intervention can ameliorate TB pathogenesis in male Nox2-/- mouse, we utilized tamibarotene (AM80), a synthetic retinoid and a RAR agonist demonstrating 10 times greater potency than ATRA.